It was shown that short-term fasting 24 hours before and after chemotherapy can reduce the cytotoxicity of neoadjuvant docetaxel/doxorubicin/cyclophosphamide treatment in HER2- BC (63, 64). The gene discussed is ERBB2; the disease is breast cancer.